Górriz José Luis, Adán Gil Fran, Botana López Manuel A, Buño Soto Antonio, Campos Cabrera Francisco José, Cisneros Angeles, Cobo Guerrero Silvia, Conejos María Dolores, Egocheaga Cabello Isabel, Fernández Planelles M Concepción, García-Matarín Lisardo, Jiménez Natalia, Julián Mauro Juan Carlos, León Jiménez David, Martínez Gamote Daniel, Mazón Ramos Pilar, Ortiz Alberto, Palau Gemma, Quevedo Rivera Julia, Sánchez-Álvarez J Emilio, Tristancho Ajamil Rita, Varga Martín Cristina, Vallés Fernández Roser
Servicio de Nefrología, Hospital Clínico Universitario. INCLIVA. Universitat de València, Valencia, Spain.
Medicina de Familia y Comunitaria, EAP Épila, Épila, Zaragoza, Spain.
Nefrologia (Engl Ed). 2025 May;45(5):351-359. doi: 10.1016/j.nefroe.2025.05.001. Epub 2025 May 27.
Chronic kidney disease (CKD) is a real public health problem. It is estimated that by 2040, approximately one in five adults will develop CKD, and that by 2050 it will be the third cause of death in Spain. However, CKD is clearly underdiagnosed, with low screening figures in the population at risk, often delaying its identification until advanced stages of the disease, which worsens prognosis and increases associated costs. In addition, drugs are now available that have been shown to reduce the progression of CKD and the risk of developing vascular complications. In this context, the early detection, diagnosis, and initial management of CKD by health organizations should become a priority, as this would reduce the burden of the disease substantially. Since this pathology is oligo, or paucisymptomatic in the initial stages, a proactive attitude is required from the health professional to detect, diagnose, and treat it early. Several publications have shown that, to date, neither the detection of CKD nor its initial management are optimal. The IntERKit project emerged with the aim of improving the early detection, diagnosis, and initial management of CKD by promoting collaboration with health organizations through tools easily implemented by these organizations. The IntERKit project provides healthcare organizations with a structured framework to optimize early management of CKD efficiently, achieving a real, measurable, sustainable, and scalable impact, which can evolve depending on the results obtained.
慢性肾脏病(CKD)是一个切实存在的公共卫生问题。据估计,到2040年,约五分之一的成年人将患上慢性肾脏病,到2050年,它将成为西班牙第三大致死原因。然而,慢性肾脏病明显存在诊断不足的情况,高危人群的筛查数据较低,往往在疾病晚期才得以确诊,这会使预后恶化并增加相关费用。此外,目前已有药物被证明可降低慢性肾脏病的进展以及发生血管并发症的风险。在此背景下,卫生组织对慢性肾脏病的早期检测、诊断及初始管理应成为优先事项,因为这将大幅减轻该疾病的负担。由于这种病症在初始阶段症状较少或不明显,因此卫生专业人员需要采取积极主动的态度来早期检测、诊断和治疗它。一些出版物表明,迄今为止,慢性肾脏病的检测及其初始管理都不尽如人意。IntERKit项目应运而生,旨在通过促进与卫生组织合作,利用这些组织易于实施的工具,来改善慢性肾脏病的早期检测、诊断及初始管理。IntERKit项目为医疗保健组织提供了一个结构化框架,以高效优化慢性肾脏病的早期管理,实现切实、可衡量、可持续且可扩展的影响,并可根据所获结果不断发展。